Publications by authors named "Degui Geng"

Claim this Profile
M
Melanoma leverages innate immune IRAK-M signaling to limit metastasis through PTPN22-Induced signaling repression.
Degui Geng, Jiangli Chen, Amelia Sanchez, Sebastian Andres Davalos, Pearl Wilcox

Cancer Lett· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
DNA-PK inhibition enhances neoantigen diversity and increases T cell responses to immunoresistant tumors.
Allison J Nielsen, Gabriella K Albert, Amelia Sanchez, Jiangli Chen, Jing Liu, Degui Geng

J Clin Invest· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Testing Cancer Immunotherapy in a Human Immune System Mouse Model: Correlating Treatment Responses to Human Chimerism, Therapeutic Variables and Immune Cell Phenotypes.
Juan A Marín-Jiménez, Anna Capasso, Matthew S Lewis, Stacey M Bagby, Sarah J Hartman, Degui Geng

Front Immunol· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Induction of IRAK-M in melanoma induces caspase-3 dependent apoptosis by reducing TRAF6 and calpastatin levels.
Degui Geng, Nicholas Ciavattone, Jackline Joy Lasola, Rojesh Shrestha, Amelia Sanchez

Commun Biol· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TLR5 Ligand-Secreting T Cells Reshape the Tumor Microenvironment and Enhance Antitumor Activity.
Degui Geng, Sabina Kaczanowska, Alexander Tsai, Kenisha Younger, Augusto Ochoa

Cancer Res· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Redirecting gene-modified T cells toward various cancer types using tagged antibodies.
Koji Tamada, Degui Geng, Yukimi Sakoda, Navneeta Bansal, Ratika Srivastava

Clin Cancer Res· December 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Augmentation of therapeutic responses in melanoma by inhibition of IRAK-1,-4.
Ratika Srivastava, Degui Geng, Yingjia Liu, Liqin Zheng, Zhaoyang Li

Cancer Res· December 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dichotomous regulation of GVHD through bidirectional functions of the BTLA-HVEM pathway.
Yukimi Sakoda, Jang-June Park, Yuming Zhao, Atsuo Kuramasu, Degui Geng

Blood· February 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
When Toll-like receptor and T-cell receptor signals collide: a mechanism for enhanced CD8 T-cell effector function.
Degui Geng, Liqin Zheng, Ratika Srivastava, Nicole Asprodites, Cruz Velasco-Gonzalez

Blood· November 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Amplifying TLR-MyD88 signals within tumor-specific T cells enhances antitumor activity to suboptimal levels of weakly immunogenic tumor antigens.
Degui Geng, Liqin Zheng, Ratika Srivastava, Cruz Velasco-Gonzalez, Adam Riker

Cancer Res· October 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Engagement of Toll-like receptor-2 on cytotoxic T-lymphocytes occurs in vivo and augments antitumor activity.
Nicole Asprodites, Liqin Zheng, Degui Geng, Cruz Velasco-Gonzalez, Luis Sanchez-Perez

FASEB J· October 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
GCSF receptor regulates antigen uptake and expression of cytokines and costimulatory molecules in dendritic cells.
Degui Geng, Sunil K Joshi, Robert Podolsky, Jin-Xiong She

Mol Immunol· January 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis